Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Jaguar Health (JAGX) Return on Capital Employed (2016 - 2025)

Jaguar Health (JAGX) has disclosed Return on Capital Employed for 11 consecutive years, with 2.34% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Capital Employed fell 158.0% to 2.34% in Q3 2025 year-over-year; TTM through Sep 2025 was 2.34%, a 158.0% decrease, with the full-year FY2024 number at 1.01%, down 4.0% from a year prior.
  • Return on Capital Employed was 2.34% for Q3 2025 at Jaguar Health, down from 1.44% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.55% in Q2 2021 to a low of 2.34% in Q3 2025.
  • A 5-year average of 1.16% and a median of 1.01% in 2023 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: skyrocketed 214bps in 2021, then plummeted -158bps in 2025.
  • Jaguar Health's Return on Capital Employed stood at 1.0% in 2021, then crashed by -81bps to 1.81% in 2022, then soared by 44bps to 1.01% in 2023, then grew by 24bps to 0.77% in 2024, then crashed by -205bps to 2.34% in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Return on Capital Employed are 2.34% (Q3 2025), 1.44% (Q2 2025), and 1.2% (Q1 2025).